Clinical Trial

Effect of Blue Light on Vagus Nerve Stimulation in Patients With Refractory Epilepsy

Study acronym: BLUELIGHTVNS
Recruiting
View on ClinicalTrials.gov →
Summary
Vagus nerve stimulation (VNS) is an adjunctive treatment for refractory epilepsy. Although widely used, there is still a substantial number of patients with insufficient response. Light, and particularly blue light, can stimulate alertness, attention and cognition through modulation of anatomical targets which are common to the vagal afferent network. This project aims at understanding how exposure to blue enriched light may influence VNS effects in patients with refractory epilepsy by exploring the modulation of a series of biomarkers of VNS action. This could possibly lead to new therapeutic strategies to increase efficacy of VNS.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-03-04.
Trial Details
NCT Number NCT06304389
Lead Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions Refractory Epilepsy
Enrollment 34 participants
Start Date 2023-07-01
Primary Completion 2023-07-01 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-09-10